 |
Metacrine
Last updated: September 15, 2024
CEO Neil McDonnell and Chairman Rich Heyman
USA | Funding: $173M (+)
Website: https://www.metacrine.com/
Metacrine is an emerging biotech company focused on developing best-in-class therapies to benefit patients with liver, gastrointestinal, and metabolic diseases.
Website: https://www.metacrine.com/
Metacrine is an emerging biotech company focused on developing best-in-class therapies to benefit patients with liver, gastrointestinal, and metabolic diseases.
